Thrombolysis in pulmonary embolism: Are we under-using it?

QJM: An International Journal of Medicine

Volumn 97, Issue 6, 2004, Pages 361-364

  Loebinger, M R ^a   Bradley, J C ^a  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ARTIFICIAL VENTILATION; BLEEDING; BLOOD CLOT LYSIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; HEART INFARCTION; HUMAN; HYPOXIA; INTERMETHOD COMPARISON; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG HEMODYNAMICS; LUNG INSUFFICIENCY; LUNG PERFUSION; NOTE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURVIVAL RATE;

EID: 3042544904     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hch069     Document Type: Note

References (23)

1. Goldhaber SZ, Visani L, De Rosa M, for ICOPER. Acute pulmonary embolism: clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER). Lancet 1999; 353:1386-9.
2. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Col Cardiol 1997; 30:1165-71.
3. Thabut G, Thabut D, Myers RP, et al. Thrombolytic therapy of pulmonary embolism. A meta-analysis. J Am Coll Cardiol 2002; 40:1660-7.
4. British Thoracic Society. British thoracic society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58:470-84.
5. Arcasoy SM, Kreit JW. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest 1999; 115:1695-707.
6. Jerjes-Sanchez C, Ramirez-Rivera A, Gareia M de L, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomised controlled trial. J Thromb Thrombolysis 1995; 2:227-9.
7. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341:507-11.
8. Kasper W, Konstantinides S, Geibel A, et al. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 1997; 77:346-9.
9. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, et al. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 1997; 134:479-87.
10. Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101:2817-22.
11. Vieillard-Baron A, Page B, Augarde R, et al. Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 2001; 27:1481-6.
12. Konstantinides S, Geibel A, Olschewski M, et al. Impact of thrombolytic treatment on the prognosis of haemodynamically stable patients with major pulmonary embolism: results of a Multicenter Registry. Circulation 1997; 96:882-8.
13. Hamel E, Pacouret G, Vincentelli D, et al. Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilatation: results from a 128-patient monocentre registry. Chest 2001; 120:120-5.
14. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347:1143-50.
15. Goldhaber SZ. Thrombolysis for pulmonary embolism [perspective]. N Engl J Med 2002; 347:1131-2.
16. Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 2003; 108:2191-4.
17. Daniels LB, Parker JA, Patel SR, Grodstein F, Goldhaber SZ. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol 1997; 80:184-8.
18. Dantzker DR, Bower JS. Clinical significance of pulmonary function tests. Alterations in gas exchange following pulmonary thromboembolism. Chest 1982; 81:495-501.
19. Stein PD, Goldhaber SZ, Henry JW. Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest 1995; 107:139-43.
20. McIntyre KM, Sasahara AA. The haemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 1971; 28:288-94.
21. Wicki J, Perrier A, Perneger TV, et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000; 84:548-52.
22. Konstantinides S, Geibel A, Kasper W, et al. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998; 97:1946-51.
23. Wood K. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of haemodynamically significant pulmonary embolism. Chest 2002; 121:877-905.